31/12/2024 false false Easy Digital Filing 2024_3 SC296459 business:PrivateLimitedCompanyLtd 2024-12-31 2025-12-30 SC296459 2024-12-31 SC296459 2025-12-30 SC296459 2024-12-30 SC296459 2024-12-31 2025-12-30 SC296459 2023-12-31 2024-12-30 SC296459 business:Director1 2024-12-31 2025-12-30 SC296459 business:Director2 2024-12-31 2025-12-30 SC296459 business:AuditExempt-NoAccountantsReport 2024-12-31 2025-12-30 SC296459 business:Micro-entities 2024-12-31 2025-12-30 SC296459 business:AbridgedAccounts 2024-12-31 2025-12-30 SC296459 false 2024-12-31 2025-12-30 SC296459 false 2025-12-30 SC296459 core:WithinOneYear 2025-12-30 SC296459 core:WithinOneYear 2024-12-30 SC296459 core:AfterOneYear 2025-12-30 SC296459 core:AfterOneYear 2024-12-30 iso4217:GBP xbrli:pure
Company Registration No. SC296459 (Scotland)

HIGHLAND BIOSCIENCES LTD
Annual Report and Statement of Accounts
For the Period from 31 December 2024 to 30 December 2025

## HIGHLAND BIOSCIENCES LTD

### Annual report and statement of accounts for the period ending 30/12/2025

CONTENTS | PAGE
Company information | 2
Balance Sheet | 3

## HIGHLAND BIOSCIENCES LTD

### Financial statement for the period ended 30/12/2025

#### Company Information

1 Statutory Information
Company Number | SC296459
Registered Office | NESS HOUSE
| DUNCANSTON
| DINGWALL
| ROSS-SHIRE
| IV7 8JD
2 Directors
Directors who held office during the period were:
DAY, Emma Vanessa Jayne, Mrs.
DAY, Richard Michael, Dr
3 Principal Activity
The principal activity of the company is the research and development of medical diagnostic devices, including a point of care blood coagulation test (Coaguscan) and related feasibility-stage projects. The company also generates revenue from professional and technical consulting services.

4 Employees
Average number of employees, including directors, during the year was as follows:
2025 | 2
2024 | 2

## HIGHLAND BIOSCIENCES LTD

### Financial statement for the period ended 30/12/2025

#### Statement of Financial Position

|  |  |  | 2025 |  |  |  | 2024
|  |  |  | £ |  |  |  | £
Fixed Assets |  |  |  | 14,939 |  |  |  | 19,788
Current Assets |  | 143,770 |  |  |  | 159,278 |  |
Creditors: amounts falling due within one year |  | (27,523) |  |  |  | (16,445) |  |
Net Current Assets |  |  |  | 116,247 |  |  |  | 142,833
Total assets less current liabilities |  |  |  | 131,186 |  |  |  | 162,621
Creditors: amounts falling due after one year |  |  |  | (23,748) |  |  |  | (31,253)
Net Assets |  |  |  | 107,438 |  |  |  | 131,368
Capital and reserves |  |  |  | 107,438 |  |  |  | 131,368

For the period ending 30/12/2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The Directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
Approved by the Board on 10 April 2026
Dr. R. M. Day
Company Registration No. SC296459